(Q38332760)

2 September 2017

title

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution (English)

1 reference

2 September 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

viral genes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

author name string

T. F. Wolfs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

G. Zwart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

M. Bakker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

M. Valk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

C. L. Kuiken

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

J. Goudsmit

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656585

22 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

2 September 2017

https://api.elsevier.com/content/article/PII:0042682291907676?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

https://api.elsevier.com/content/article/PII:0042682291907676?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

22 October 2022

1 reference

2 September 2017

volume

185

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

195-205

1 reference

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

2 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations

22 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Rapid and simple method for purification of nucleic acids

22 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

22 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Antigenic variation in lentiviral diseases

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

22 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals.

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Biologically diverse molecular variants within a single HIV-1 isolate

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

22 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

22 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Characterization of HIV-1 neutralization escape mutants

22 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

22 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations

22 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Antigenic Shift of Visna Virus in Persistently Infected Sheep

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus

22 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease.

22 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

22 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Extensive variation of human immunodeficiency virus type-1 in vivo

22 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

22 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

22 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

22 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

22 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0042-6822(91)90767-6

22 October 2022

Identifiers

1 reference

2 September 2017

1 reference